mi.amankwah

TL2 · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 27 June 2025 · last posted 8d

88 posts, newest first. Showing up to 150.

GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #48 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 0 likes I changed my mind about GHRH analogues versus ghrelin mimetics after someone here asked me for the source and I could not produce one. That is worth saying out loud…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #60 · Start Here › Welcome · 19 Jul 2026 · 29 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #16 · Analytics › Impurities & related substances · 12 Jul 2026 · 0 likes Worth separating Racemisation as a question about the compound from Racemisation as a question about the documentation. They get answered by different people and only…
What a good consultation looks like from the other side Replied, post #57 · Clinical › Prescriber conversations · 8 Jul 2026 · 32 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. Small methodological point on good consultation: repeating a measurement is cheap…
How much context is too much context in a first post? Replied, post #46 · Start Here › How to Ask · 8 Jul 2026 · 23 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Sleep quality changes during weight loss Replied, post #12 · Wellbeing › Sleep · 8 Jul 2026 · 32 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
How shortages have affected compounding permissions — does this still hold? Replied, post #22 · Access › Shortages · 6 Jul 2026 · 0 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
Insurance and replacement policies, compared Replied, post #63 · Sourcing › Logistics · 4 Jul 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. A single observation, in a thread…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #30 · Compounds › Retatrutide · 1 Jul 2026 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #28 · Pharmacology › Receptor biology · 26 Jun 2026 · 0 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
Publication bias detection and its low power Started this topic · Evidence › Meta-analyses · 16 Jun 2026 · 4 likes On the subject in the title: Publication bias detection and its low power Working notes rather than a conclusion. Working notes on publication bias detection rather…
Follow-up: Sleep quality changes during weight loss Replied, post #39 · Wellbeing › Sleep · 7 Jun 2026 · 19 likes A referral for a proper sleep study answers in one night what months of forum discussion cannot. The claim is narrower than it sounds, and deliberately so.
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #68 · Practice › Administration · 26 May 2026 · 6 likes Fair, and the limits you put on it are the part I will remember.
Insomnia at a dose step: reported experiences — the long version Replied, post #26 · Wellbeing › Sleep · 26 May 2026 · 11 likes Waking at night with nausea is described commonly here and is a timing question as much as a dose question.
What I would want from a home test that does not exist yet — what changed since Replied, post #24 · Analytics › Home & field testing · 18 May 2026 · 1 like Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #126 · Compounds › Tirzepatide · 16 May 2026 · 4 likes The number people quote for 2.5 mg starting dose is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
Step therapy requirements and how to satisfy them Replied, post #11 · Access › Insurance & coverage · 4 May 2026 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
When a dose reduction is the correct response to a side effect Replied, post #17 · Practice › Dosing & titration · 2 May 2026 · 16 likes Worth separating two things that post #13 runs together. Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the…
Five questions in one post gets you one answer — how to split them Replied, post #68 · Start Here › How to Ask · 30 Apr 2026 · 19 likes On post #66 — agreed on the reasoning, with one qualification. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
Journal club: is percentage weight change the right endpoint? Replied, post #107 · Evidence › Journal club · 26 Apr 2026 · 14 likes Confirming post #104 from a second method, which matters more than confirming it from a second person. The most common failure mode is spending fifty minutes on the…
Area percent versus weight percent: the confusion that causes most arguments Replied, post #6 · Analytics › HPLC & UHPLC · 26 Apr 2026 · 8 likes Mobile-phase preparation is a genuine source of between-laboratory variation. Acid concentration and organic modifier both shift retention, and neither is usually…
Getting a referral rather than a refusal Replied, post #10 · Clinical › Prescriber conversations · 11 Apr 2026 · 3 likes I disagree with the framing of getting a referral above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
Cold solution and stinging: the simplest fix Replied, post #13 · Practice › Administration · 4 Apr 2026 · 16 likes No notes. Posting so the count is not one.
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #28 · Start Here › Welcome · 3 Apr 2026 · 3 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
Transporting a vial for a weekend away — a second dataset Replied, post #8 · Practice › Storage & stability · 16 Mar 2026 · 23 likes Taking post #5 at face value and following it one step further. What I would tell a new member reading about Transporting a vial for the first time: the confident posts…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #71 · Practice › Dosing & titration · 18 Feb 2026 · 0 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #44 · Clinical › Special populations · 16 Feb 2026 · 27 likes Post #43 describes the usual case. This is about the unusual one. What I would check first on pregnancy and pregnancy planning is whether the thing being measured moved…
Second pass at: Identical chromatograms across two different lots Replied, post #6 · Sourcing › Red flags · 13 Feb 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
Trifluoroacetate content and its consequences Replied, post #134 · Analytics › Impurities & related substances · 12 Feb 2026 · 21 likes The failure mode on trifluoroacetate content is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
Documenting a payment dispute without naming and shaming — the long version Started this topic · Sourcing › Payments · 6 Feb 2026 · 7 likes Posting this under the heading it deserves: Documenting a payment dispute without naming and shaming — the long version Everything below is what sits behind that. A…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #93 · Clinical › Special populations · 5 Feb 2026 · 3 likes Confirming post #92 from a second method, which matters more than confirming it from a second person. Posting my older adults numbers with the method attached so they…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #94 · Clinical › Special populations · 26 Jan 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #75 · Clinical › Special populations · 25 Jan 2026 · 0 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #7 · Practice › Administration · 8 Jan 2026 · 24 likes The strongest argument against my own position on Pinch, stated as well as I can state it, since nobody else has yet.
Coverage in the US: a map of the usual obstacles Replied, post #28 · Regional › North America · 27 Dec 2025 · 10 likes Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account. Old habit: I write down the expected answer before…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #47 · Analytics › Method validation · 14 Dec 2025 · 1 like My experience of Specificity contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
Tracking a preprint to publication: a worked example Replied, post #97 · Evidence › Preprints · 10 Dec 2025 · 29 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
DXA precision and the least significant change for lean mass Replied, post #47 · Outcomes › Body composition · 6 Dec 2025 · 8 likes Post #44 answers the question as asked. The question underneath it is different. I would call the community position on DXA precision likely rather than established,…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #60 · Practice › Interactions · 1 Dec 2025 · 0 likes I disagree with the framing of Warfarin and altered intake above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #13 · Compounds › Other compounds · 22 Nov 2025 · 0 likes For any compound without a widely available reference standard, retention-time comparisons across laboratories are close to meaningless. Only a mass result travels.
Follow-up: Why appetite effects are mostly central Replied, post #87 · Pharmacology › Receptor biology · 5 Nov 2025 · 22 likes The reason appetite effects is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
Absolute versus relative contraindications Replied, post #3 · Safety › Contraindications · 4 Nov 2025 · 27 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. History of pancreatitis: these compounds can rarely trigger…
Where to report an adverse event officially, by region — a second dataset Replied, post #14 · Safety › Adverse events · 12 Oct 2025 · 14 likes Where a member describes something concerning, escalating the thread rather than continuing it is a moderation practice rather than a dismissal.
Pinch or no pinch, and how needle length changes the answer Replied, post #93 · Practice › Administration · 4 Oct 2025 · 9 likes The arithmetic on pinch is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Documentation that materially improves an appeal's chances Replied, post #12 · Access › Insurance & coverage · 28 Sep 2025 · 2 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #129 · Access › Insurance & coverage · 21 Sep 2025 · 1 like Marking my uncertainty on Reading a denial letter explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
About the Prescriber conversations category Replied, post #6 · Clinical › Prescriber conversations · 15 Sep 2025 · 5 likes Adding the measurement that post #5 says would settle it. If you have been doing something the prescriber does not know about, saying so is more useful than not.…
Coming back to: What published stability data actually covers, and what it does not Replied, post #138 · Practice › Storage & stability · 12 Sep 2025 · 0 likes Two people in this thread mean different things by published stability data actually covers and are disagreeing about the definition while believing they are…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #72 · Clinical › Special populations · 1 Sep 2025 · 19 likes Narrowing post #71, because the general version has more than one answer. I disagree with the framing of History of disordered eating above, and I think it is a…
Research-use-only labelling: what it means and what it does not Replied, post #25 · Sourcing › Regulatory · 23 Aug 2025 · 0 likes This follows post #22 rather than contradicting it. Something worth flagging about research-use-only labelling: the strongest-sounding claims in this thread are the…
Regional warehouse stock versus direct despatch Replied, post #10 · Sourcing › Logistics · 20 Aug 2025 · 21 likes Post #6 put the caveat in the right place and I want to underline it. Peak periods and public holidays affect this more than any other factor and are entirely…
Column chemistry choices for a 40-residue peptide Replied, post #16 · Analytics › HPLC & UHPLC · 19 Aug 2025 · 10 likes Answering the question post #14 raises rather than the one it answers. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species'…
A request that was declined, and the reasoning — a second dataset Replied, post #67 · Documentation › Wiki requests · 12 Aug 2025 · 16 likes Same experience here, different supplier, so it is at least not unique to one of them.
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #5 · Data & Tools › Datasets · 27 Jul 2025 · 6 likes A dataset is only useful if the collection method is described alongside it. Numbers without a protocol are a list rather than data. I have kept the units in…
Why oral semaglutide needs an absorption enhancer at all Replied, post #21 · Compounds › Oral incretins · 26 Jul 2025 · 0 likes Worth separating two things that post #17 runs together. The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #11 · Analytics › Method validation · 26 Jun 2025 · 8 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. Why two laboratories may disagree: after validating the same method, they may still…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #35 · Evidence › Trials · 15 Jun 2025 · 1 like Post #32 put the caveat in the right place and I want to underline it. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
[2026 update] An appeal that failed, and what I would do differently Replied, post #58 · Access › Insurance & coverage · 10 Jun 2025 · 0 likes Small methodological point on appeal: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Counter-ion content and its effect on measured mass Replied, post #46 · Analytics › Mass spectrometry · 23 May 2025 · 29 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #4 · Evidence › Journal club · 13 May 2025 · 3 likes This follows post #2 rather than contradicting it. The figures usually contain the finding and the text usually contains the interpretation. Separating them for the…
A claim built entirely on a subgroup analysis Replied, post #30 · Evidence › Study critique · 12 May 2025 · 1 like Nothing to add on the substance. Thank you for taking the question at face value.
Water content on a certificate and why it changes the arithmetic Replied, post #17 · Analytics › COA interpretation · 10 May 2025 · 1 like Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
SURMOUNT-4 and what withdrawal data does and does not tell an individual Replied, post #3 · Compounds › Tirzepatide · 3 May 2025 · 8 likes Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #107 · Evidence › Journal club · 22 Apr 2025 · 26 likes One caution on STEP 1: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #45 · Compounds › Other compounds · 22 Apr 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #6 · Clinical › Bloodwork · 13 Apr 2025 · 16 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. The variance between people here is larger…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #39 · Compounds › Secretagogues & GH axis · 8 Apr 2025 · 0 likes Everything in post #35 holds. The case it does not cover is the one I have. Tesamorelin is worth one more sentence than it usually gets, and the sentence is the one…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #73 · Devices › Cold chain · 25 Mar 2025 · 26 likes The arithmetic in post #70 is right; the assumption feeding it is the part to check. Shipment during summer or to hot climates: consider shipping to a cold-storage…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #5 · Clinical › Comorbidities · 20 Mar 2025 · 4 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #55 · Sourcing › Vendor reports · 16 Mar 2025 · 3 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. Posted with less confidence…
Retatrutide dose escalation in the published trials Replied, post #16 · Compounds › Retatrutide · 15 Mar 2025 · 0 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #62 · Pharmacology › Receptor biology · 8 Mar 2025 · 0 likes Half-life extension by albumin binding through a fatty acid chain trades free fraction for duration. It is an engineering solution with a cost, and the cost is that the…
When "no data" is the complete and final answer Replied, post #108 · Compounds › Other compounds · 3 Mar 2025 · 0 likes Narrowing post #107, because the general version has more than one answer. When "no data" is the complete and final answer: if there is no published human data on a…
Why mass spectrometry cannot tell you about an epimer Replied, post #74 · Analytics › Mass spectrometry · 1 Mar 2025 · 11 likes Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A finding at trace level may be telling you about the preparation…
Distinguishing a deletion sequence by mass alone Replied, post #118 · Analytics › Mass spectrometry · 22 Feb 2025 · 2 likes I have three months of notes on distinguishing a deletion sequence and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #64 · Compounds › Secretagogues & GH axis · 2 Feb 2025 · 2 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
A promotion I argued against, and why I lost Replied, post #68 · Documentation › Doc review · 20 Jan 2025 · 23 likes A promotion that is declined should leave the topic linked from wherever the question recurs, so the work is not lost. Adding it because I spent an afternoon working it…
Follow-up: Individual participant data versus aggregate data Replied, post #89 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes Post #85 put the caveat in the right place and I want to underline it. Adding the boring version of Individual participant data versus aggregate, because the…
Oxidation pathways for methionine and tryptophan Replied, post #47 · Analytics › Impurities & related substances · 29 Dec 2024 · 0 likes Taking post #44 at face value and following it one step further. Second-hand on oxidation pathways for methionine, so weight it accordingly — someone whose method I…
Reading a supplementary appendix and finding the interesting part Replied, post #54 · Evidence › Trials · 28 Dec 2024 · 15 likes Post #50 put the caveat in the right place and I want to underline it. On reading a supplementary appendix: the maintained page in the documentation commons covers the…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #24 · Compounds › Semaglutide · 21 Dec 2024 · 0 likes On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation. A reconstituted research preparation matches neither, and…
Follow-up: What this community means by "a source", in practical terms Replied, post #16 · Start Here › Welcome · 8 Dec 2024 · 0 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
Washout with a one-week half-life: the arithmetic Replied, post #46 · Research Methods › N-of-1 designs · 1 Dec 2024 · 21 likes Picking up post #45: that is the part I would want checked first. My understanding of washout is a few years old and may have been superseded. If it has been, I would…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #83 · Clinical › Prescriber conversations · 22 Oct 2024 · 23 likes Adding thanks rather than a view. I do not have a view worth the space.
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #18 · Practice › Administration · 9 Sep 2024 · 0 likes Site rotation scheme has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Circumference measurements as a poor man's composition estimate Replied, post #11 · Outcomes › Body composition · 21 Jul 2024 · 2 likes Reading this circumference measurements thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
The mass-error checker and its intended scope Replied, post #78 · Data & Tools › Calculators · 26 Jun 2024 · 30 likes What I would check first on mass-error checker is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #10 · Clinical › Prescriber conversations · 23 Jun 2024 · 4 likes Everything in post #6 holds. The case it does not cover is the one I have. Prescription logistics: confirm whether it will be filled locally, requires mail order, or…